New trial data on Dronabinol for PTSD highlights critical gaps in CNS clinical trial design. Learn why trial methodology is failing to capture efficacy.
Kymera Therapeutics completes enrollment for its KT-621 trial six months early, marking a major milestone in developing new treatments for atopic dermatitis.
A new clinical trial for rebecsinib offers a breakthrough approach to treating aggressive blood cancers like AML and MDS. Learn about this targeted therapy.
A tragic pediatric death in a Chinese gene-editing trial has reignited global concerns over safety, ethics, and the need for greater clinical transparency.
A new standardized clinical trial framework for Charcot-Marie-Tooth disease aims to speed up drug development and improve treatment outcomes for patients.